Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Myostatin, a member of the transforming growth factor-beta (TGF-beta) superfamily, has been shown to be a negative regulator of myogenesis. Here we show that myostatin functions by controlling the proliferation of muscle precursor cells. When C(2)C(12) myoblasts were incubated with myostatin, proliferation of myoblasts decreased with increasing levels of myostatin. Fluorescence-activated cell sorting analysis revealed that myostatin prevented the progression of myoblasts from the G(1)- to S-phase of the cell cycle. Western analysis indicated that myostatin specifically up-regulated p21(Waf1, Cip1), a cyclin-dependent kinase inhibitor, and decreased the levels and activity of Cdk2 protein in myoblasts. Furthermore, we also observed that in myoblasts treated with myostatin protein, Rb was predominately present in the hypophosphorylated form. These results suggests that, in response to myostatin signaling, there is an increase in p21 expression and a decrease in Cdk2 protein and activity thus resulting in an accumulation of hypophosphorylated Rb protein. This, in turn, leads to the arrest of myoblasts in G(1)-phase of cell cycle. Thus, we propose that the generalized muscular hyperplasia phenotype observed in animals that lack functional myostatin could be as a result of deregulated myoblast proliferation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Myostatin is a cytokine that works by inhibiting the proliferation of satellite cells and the differentiation of myoblasts [10], while also decreasing adipogenesis via reductions in the secretion of leptin [11].”
From Effects of methoxyisoflavone, ecdysterone, and sulfo-polysaccharide supplementation on training adaptations in resistance-trained males (2006) · cites this paper as [10]
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle
YAFFE, D., & SAXEL, O. (1977) · Nature · doi:10.1038/270725a0 · Cited by 2,123
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
MyoD or Myf-5 is required for the formation of skeletal muscle
Rudnicki, M. A., Schnegelsberg, P. N. J., Stead, R. H., Braun, T., Arnold, H.-H., & Jaenisch, R. (1993) · Cell · doi:10.1016/0092-8674(93)90621-v · Cited by 1,731
A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Research works printed but not linked: 1
- Ji, 1998, Am. J. Physiol., 275(4 Pt 2),, R1265
Cited by
Items 101–200 of 1,000
Wilkes, J. J., Lloyd, D. J., & Gekakis, N. (2009) · Diabetes · doi:10.2337/db08-0245 · Cited by 156
“In wild-type mice, multiple processing steps generate active Mstn ligand, which binds activin type 2 receptors (ActRIIa and ActRIIb) (13), from its precursor (14).”
BackgroundMyostatin Regulates Cell Survival during C2C12 Myogenesis
Ríos, R., Carneiro, I., Arce, V. M., & Devesa, J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4159 · Cited by 189
Impact of ageing on muscle cell regeneration
Carosio, S., Berardinelli, M. G., Aucello, M., & Musarò, A. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.08.001 · Cited by 192
“Myostatin negatively regulates myoblast proliferation through up-regulation of p21 and inactivation of cyclin-dependent kinase (Cdk), resulting in retinoblastoma (Rb) hypophosphorylation and myoblast cell cycle arrest (Rios et al., 2001; Thomas et al., 2000).”
Multiple Effects of Growth Hormone in the Body: Is it Really the Hormone for Growth?
Devesa, J., Almengló, C., & Devesa, P. (2016) · Clinical Medicine Insights: Endocrinology and Diabetes · doi:10.4137/cmed.s38201 · Cited by 153
Regulation of Myostatin on the Growth and Development of Skeletal Muscle
Chen, M.-M., Zhao, Y.-P., Zhao, Y., Deng, S.-L., & Yu, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.785712 · Cited by 151
Regulation of GDF-8 signaling by the p38 MAPK
Philip, B., Lu, Z., & Gao, Y. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.08.003 · Cited by 152
Therapeutic approaches for muscle wasting disorders
Lynch, G. S., Schertzer, J. D., & Ryall, J. G. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.004 · Cited by 169
Signaling pathways weigh in on decisions to make or break skeletal muscle
Guttridge, D. C. (2004) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/01.mco.0000134364.61406.26 · Cited by 149
Myostatin: A novel insight into its role in metabolism, signal pathways, and expression regulation
Huang, Z., Chen, X., & Chen, D. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.05.003 · Cited by 176
Wasting mechanisms in muscular dystrophy
Shin, J. S., Tajrishi, M. M., Ogura, Y., & Kumar, A. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.001 · Cited by 162
Muscle function in COPD: a complex interplay
Man, W., Donaldson, Maddocks, Martolini, & Polkey, M. (2012) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s28247 · Cited by 147
Yang, W., Chen, Y., Zhang, Y., Wang, X., Yang, N., & Zhu, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3060 · Cited by 144
“and a decreased cyclin E/Cdk2 activity, which further caused the hypophosphorylation of Rb protein (11).”
BackgroundSouza, T. A., Chen, X., Guo, Y., Sava, P., Zhang, J., Hill, J. J., Yaworsky, P. J., & Qiu, Y. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0290 · Cited by 142
Double Muscling in Cattle: Genes, Husbandry, Carcasses and Meat
Fiems, L. O. (2012) · Animals · doi:10.3390/ani2030472 · Cited by 141
“At a cellular level, MSTN affects cell cycling by controlling the entry of satellite cells into the S phase [148–150].”
BackgroundProlonged absence of myostatin reduces sarcopenia
Siriett, V., Platt, L., Salerno, M. S., Ling, N., Kambadur, R., & Sharma, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20778 · Cited by 140
“Studies indicate myostatin regulates cell cycle progression and myogenic regulatory factor levels (MRFs), thereby controlling myoblast proliferation and differentiation during developmental myogenesis (Thomas et al., 2000; Langley et al., 2002).”
BackgroundSelf-citationAmthor, H., Huang, R., McKinnell, I., Christ, B., Kambadur, R., Sharma, M., & Patel, K. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0812 · Cited by 139
“In vitro analysis has shown a repression of myoblast proliferation (Taylor et al., 2001; Thomas et al., 2000).”
BackgroundSelf-citationSarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass
Sakuma, K., & Yamaguchi, A. (2012) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-011-0052-4 · Cited by 137
ERK2 is required for efficient terminal differentiation of skeletal myoblasts
Li, J., & Johnson, S. E. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.051 · Cited by 137
“Myostatin inhibits myoblast proliferation through increasing p21 expression and decrease Cdk2 expression leading to an accumulation of Rb protein, which in turn arrests myoblasts in G1 phase of cell cycle [176].”
Therapeutics for Duchenne muscular dystrophy: current approaches and future directions
Bogdanovich, S., Perkins, K. J., Krag, T. O. B., & Khurana, T. S. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0484-1 · Cited by 154
“of myostatin action appears similar to those exhibited by members of the TGF-b superfamily [151, 156, 157, 158].”
BackgroundAmthor, H., Christ, B., Rashid-Doubell, F., Kemp, C. F., Lang, E., & Patel, K. (2002) · Developmental Biology · doi:10.1006/dbio.2001.0555 · Cited by 136
“Myostatin prevents hyperplasia and hypertrophy muscle, and in vitro, it inhibits muscle differentiation (McPherron et al., 1997; Taylor et al., 2001; Thomas et al., 2000; Zhu et al., 2000).”
BackgroundSáinz, N., Rodríguez, A., Catalán, V., Becerril, S., Ramírez, B., Gómez-Ambrosi, J., & Frühbeck, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006808 · Cited by 135
“Myostatin inhibits the progression from the G1 to the S phase in myoblasts [74], blocks the expression of cyclin D1 and induces its degradation by the UPS [75,76].”
BackgroundPatel, K., & Amthor, H. (2005) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.10.018 · Cited by 134
Fantastically plastic: fish larvae equipped for a new world
Pittman, K., Yúfera, M., Pavlidis, M. A., Geffen, A. J., Koven, W., Ribeiro, L., Zambonino‐Infante, J., & Tandler, A. (2013) · Reviews in Aquaculture · doi:10.1111/raq.12034 · Cited by 162
“1), S224–S267 © 2013 Wiley Publishing Asia Pty Ltd S249 growth and development, by inhibiting specifically myoblast proliferation via cell-cycle arrest (Thomas et al. 2000).”
BackgroundRescan, P., Jutel, I., & Rallière, C. (2001) · Journal of Experimental Biology · doi:10.1242/jeb.204.20.3523 · Cited by 152
Johansen, K. A., & Overturf, K. (2006) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2006.02.001 · Cited by 133
“The MEF2s are thought to control mainly differentiation (Black and Olson, 1998), while the myostatins are negative regulators of both specification and differentiation (Thomas et al., 2000; Langley et al., 2002).”
Comparison of chicken genotypes: myofiber number in pectoralis muscle and myostatin ontogeny
SCHEUERMANN, G. N., Bilgili, S. F., Tuzun, S., & Mulvaney, D. R. (2004) · Poultry Science · doi:10.1093/ps/83.8.1404 · Cited by 152
“…proliferation and differentiation of myoblasts into myotubes, such that an increased myoblast proliferation rate is expected to increase the MFN, resulting in stimulation of muscle growth and enlargement of muscle size (Coutinho et al., 1993; Thomas et al., 2000; Christ and Brand-Saberi, 2002).”
BackgroundAntagonism of Myostatin Enhances Muscle Regeneration During Sarcopenia
Siriett, V., Salerno, M. S., Berry, C., Nicholas, G., Bower, R., Kambadur, R., & Sharma, M. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300182 · Cited by 132
Self-citationKishioka, Y., Thomas, M., Wakamatsu, J., Hattori, A., Sharma, M., Kambadur, R., & Nishimura, T. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21371 · Cited by 130
“Myostatin (3 mg/ml; Thomas et al., 2000) was added to them and the cells were incubated for 15 min in the media with/ without myostatin.”
BackgroundMethodInfluentialSelf-citationEspino-González, E., Dalbram, E., Mounier, R., Gondin, J., Farup, J., Jessen, N., & Treebak, J. T. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.02.014 · Cited by 154
Rodgers, B. D., Weber, G. M., Sullivan, C. V., & Levine, M. A. (2001) · Endocrinology · doi:10.1210/endo.142.4.8097 · Cited by 142
“(26) recently demonstrated that recombinant bovine MSTN inhibits myoblast proliferation in a direct and dose-dependent manner.”
Role of extracellular matrix in development of skeletal muscle and postmortem aging of meat
Nishimura, T. (2015) · Meat Science · doi:10.1016/j.meatsci.2015.05.015 · Cited by 151
Steelman, C. A., Recknor, J. C., Nettleton, D., & Reecy, J. M. (2006) · The FASEB Journal · doi:10.1096/fj.05-5125fje · Cited by 129
Molecular regulation of tendon cell fate during development
Huang, A. H., Lu, H. H., & Schweitzer, R. (2015) · Journal of Orthopaedic Research® · doi:10.1002/jor.22834 · Cited by 138
Johansen, K. A., & Overturf, K. (2005) · Marine Biotechnology · doi:10.1007/s10126-004-5133-3 · Cited by 138
“Myostatin is a secreted protein of the transforming growth factor b (TGFb) family that acts as an antagonist to muscle growth by inhibiting both myoblast proliferation and differentiation (Thomas et al., 2000; Langley et al., 2002).”
BackgroundIdentification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting
Lokireddy, S., Wijesoma, I. W., Sze, S. K., McFarlane, C., Kambadur, R., & Sharma, M. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00402.2011 · Cited by 125
Self-citationSkeletal Muscle Stem Cells: Effects of Aging and Metabolism on Muscle Regenerative Function
Jang, Y. C., Sinha, M., Cerletti, M., Dall'Osso, C., & Wagers, A. J. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010652 · Cited by 127
Myostatin: more than just a regulator of muscle mass
Argilés, J. M., Orpí, M., Busquets, S., & López-Soriano, F. J. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.02.001 · Cited by 125
Lokireddy, S., Mouly, V., Butler-Browne, G., Gluckman, P. D., Sharma, M., Kambadur, R., & McFarlane, C. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00114.2011 · Cited by 121
Self-citationSatellite Cells Contribution to Exercise Mediated Muscle Hypertrophy and Repair.
Bazgir, B., Fathi, R., Valojerdi, M. R., Mozdziak, P. E., & Asgari, A. (2017) · PubMed · doi:10.22074/cellj.2016.4714 · Cited by 121
“They observed a significant decrease in myostatin, increased FGF-2, and no change in TGF-β.”
BackgroundAn overview of the endocrinology of skeletal muscle
Sheffield‐Moore, M., & Urban, R. J. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.02.009 · Cited by 135
Kocabas, A. M., Kucuktas, H., Dunham, R. A., & Liu, Z. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00289-0 · Cited by 129
Molecular Adaptations to Aerobic Exercise Training in Skeletal Muscle of Older Women
Konopka, A. R., Douglass, M. D., Kaminsky, L. A., Jemiolo, B., Trappe, T. A., Trappe, S., & Harber, M. P. (2010) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glq109 · Cited by 123
Aswad, H., Jalabert, A., & Rome, S. (2016) · BMC Biotechnology · doi:10.1186/s12896-016-0262-0 · Cited by 122
Amali, A. A., Lin, C. J., Chen, Y., Wang, W., Gong, H., Lee, C., Ko, Y., Lu, J., Her, G. M., Chen, T. T., et al. (2004) · Developmental Dynamics · doi:10.1002/dvdy.10454 · Cited by 127
“It has also been shown that animals lacking myostatin gene have more myoblast and, thus, can form more muscle fibers (Thomas et al., 2000).”
BackgroundMuscular atrophy of caveolin-3–deficient mice is rescued by myostatin inhibition
Ohsawa, Y., Hagiwara, H., Nakatani, M., Yasue, A., Moriyama, K., Murakami, T., Tsuchida, K., Noji, S., & Sunada, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28520 · Cited by 120
“org Volume 116 Number 11 November 2006 Also, there was no change in the mRNA level of p15, a myostatinindependent CDK inhibitor (22) (Figure 5C).”
InfluentialSharma, M., McFarlane, C., Kambadur, R., Kukreti, H., Bonala, S., & Srinivasan, S. (2015) · IUBMB Life · doi:10.1002/iub.1392 · Cited by 118
“5/26 kDa mature peptide, corresponding to a C-terminal monomer or dimer respectively, have been observed ((9,22), (24); Fig.”
BackgroundSelf-citationGenetics of Athletic Performance
Ostrander, E. A., Huson, H. J., & Ostrander, G. K. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082908-150058 · Cited by 169
MicroRNA-27a promotes myoblast proliferation by targeting myostatin
Huang, Z., Chen, X., Yu, B., He, J., & Chen, D. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.106 · Cited by 129
Long noncoding RNAs, emerging players in muscle differentiation and disease
Neguembor, M. V., Jothi, M., & Gabellini, D. (2014) · Skeletal Muscle · doi:10.1186/2044-5040-4-8 · Cited by 142
“Intriguingly, Malat1 has been recently identified as a novel downstream target of myostatin [59], an important regulator of myoblast proliferation, differentiation and skeletal muscle mass [90].”
BackgroundAlcohol Abuse: Critical Pathophysiological Processes and Contribution to Disease Burden
Molina, P. E., Gardner, J. D., Souza‐Smith, F. M., & Whitaker, A. M. (2014) · Physiology · doi:10.1152/physiol.00055.2013 · Cited by 137
SUGIYAMA, A., HATA, S., SUZUKI, K., YOSHIDA, E., NAKANO, R., MITRA, S., ARASHIDA, R., ASAYAMA, Y., YABUTA, Y., & TAKEUCHI, T. (2010) · Journal of Veterinary Medical Science · doi:10.1292/jvms.09-0526 · Cited by 116
“The mechanism for this antianabolic effect of glucocorticoid is not completely understood, but it is consistent with the up-regulation by glucocorticoid of a negative myogenic regulatory protein, myostain [21], which inhibits proliferation of muscle satellite precursor cells [36, 38].”
BackgroundHuman myostatin negatively regulates human myoblast growth and differentiation
McFarlane, C., Hui, G. Z., Amanda, W. Z. W., Lau, H. Y., Lokireddy, S., XiaoJia, G., Mouly, V., Butler-Browne, G., Gluckman, P. D., Sharma, M., et al. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00012.2011 · Cited by 115
“Proliferation assay and differentiation studies on myoblasts were conducted as 106 described (17, 29).”
BackgroundMethodSelf-citationTitin‐cap associates with, and regulates secretion of, Myostatin
Nicholas, G., Thomas, M., Langley, B. C., Somers, W., Patel, K., Kemp, C. F., Sharma, M., & Kambadur, R. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10158 · Cited by 143
“Although Myostatin has been shown to be proteolytically processed and secreted (Thomas et al., 2000), factors controlling Myostatin secretion have not been identified.”
BackgroundMethodSelf-citationSerum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease
Ju, C.-R., & Chen, R.-C. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2011.07.016 · Cited by 114
“Myostatin is a new member of transforming growth factor-beta superfamily and first reported in 1997 by McPherron et al. 18 Since its discovery, myostatin has quickly been attracted much attention as a key regulator of skeletal muscle mass in both animals 19 and humans.”
BackgroundMyomaker, Regulated by MYOD, MYOG and miR-140-3p, Promotes Chicken Myoblast Fusion
Luo, W., Li, E., Nie, Q., & Zhang, X. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125946 · Cited by 139
“A previous study showed that miR-140-3p was immediately down-regulated in skeletal muscle within one hour of refeeding after fasting for one week [33], and target prediction and expressional analyses suggested that miR-140-3p might bind and inhibit the expression of the myostatin gene, which is a well-known negative r…”
MethodMuscle Atrophy After ACL Injury: Implications for Clinical Practice
Lepley, L. K., Davi, S. M., Burland, J. P., & Lepley, A. S. (2020) · Sports Health A Multidisciplinary Approach · doi:10.1177/1941738120944256 · Cited by 128
“Myostatin has also been shown to negatively affect muscle tissue formation by inhibiting differentiation.(44,85) Notably, others have also found that myostatin is highly colocalized with satellite cells(57) and functionally plays a key role in regulating satellite cell function and promoting the overexpression of fact…”
BackgroundMyostatin auto-regulates its expression by feedback loop through Smad7 dependent mechanism.
Forbes, D., Jackman, M., Bishop, A., Thomas, M., Kambadur, R., & Sharma, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20477 · Cited by 90
“Thus myostatin is considered a potent negative regulator of myogenesis in both prenatal and postnatal muscle (Thomas et al., 2000; Langley et al., 2002; McCroskery et al., 2003).”
BackgroundMethodInfluentialSelf-citationMyostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
Rodgers, B. D., & Ward, C. W. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab030 · Cited by 111
Garikipati, D. K., Gahr, S. A., & Rodgers, B. D. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06866 · Cited by 119
“Increased muscle growth in all these models results from both muscle cell hyperplasia and hypertrophy as myostatin influences myosatellite cells directly (Thomas et al. 2000, Rios et al. 2001, 2002, Langley et al. 2002, 2004, McCroskery et al. 2003).”
BackgroundYamada, M., Tatsumi, R., Yamanouchi, K., Hosoyama, T., Shiratsuchi, S.-I., Sato, A., Mizunoya, W., Ikeuchi, Y., Furuse, M., & Allen, R. E. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00449.2009 · Cited by 108
“As a result, satellite cells return to quiescent, undifferentiated state, and activation is blocked to maintain quiescence (48, 57, 91, 95).”
BackgroundInfluentialEvolving Therapeutic Strategies for Duchenne Muscular Dystrophy: Targeting Downstream Events
Tidball, J. G., & Wehling‐Henricks, M. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000145578.01985.d0 · Cited by 121
Characterization and identification of the inhibitory domain of GDF-8 propeptide
Jiang, M., Liang, L., Wang, S., Ratovitski, T., Holmstrom, J., Barker, C., & Stotish, R. L. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.085 · Cited by 119
Noncoding RNAs, Emerging Regulators of Skeletal Muscle Development and Diseases
Nie, M., Deng, Z., Liu, J., & Wang, D. (2015) · BioMed Research International · doi:10.1155/2015/676575 · Cited by 112
“During muscle differentiation, Malat1 is upregulated, and it has been identified as a downstream target of myostatin, a well-known negative regulator of myogenesis [175].”
BackgroundSnijders, T., Verdijk, L. B., Smeets, J. S. J., McKay, B. R., Senden, J. M., Hartgens, F., Parise, G., Greenhaff, P. L., & van Loon, L. J. C. (2014) · AGE · doi:10.1007/s11357-014-9699-z · Cited by 123
“In vitro studies have demonstrated that myostatin completely blocks myoblast proliferation and differentiation by the downregulation of MyoD (Taylor et al. 2001; Thomas et al. 2000; Langley et al. 2002).”
BackgroundMyostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass
Magee, T. R., Artaza, J. N., Ferrini, M. G., Vernet, D., Zuniga, F. I., Cantini, L., Reisz‐Porszasz, S., Rajfer, J., & Gonzalez‐Cadavid, N. F. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.946 · Cited by 106
“Myostatin is known to control the number of myofibers during fetal skeletal muscle development, but in adult skeletal muscle growth, it may act by simply controlling the proliferation of satellite cells, as has been shown in vitro [2,3,5,6,42].”
BackgroundSmad3 signaling is required for satellite cell function and myogenic differentiation of myoblasts
Ge, X., McFarlane, C., Vajjala, A., Lokireddy, S., Zhi Hui Melissa, N. G., Tan, C. K., Tan, N. S., Wahli, W., Sharma, M., & Kambadur, R. (2011) · Cell Research · doi:10.1038/cr.2011.72 · Cited by 112
Self-citationEfficient Generation of Myostatin (MSTN) Biallelic Mutations in Cattle Using Zinc Finger Nucleases
Luo, J., Song, Z., Yu, S., Cui, D., Wang, B., Ding, F., Song, L., Dai, Y., & Li, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095225 · Cited by 114
“Myostatin (MSTN), also named growth/differentiation factor-8, is a member of the transforming growth factor-b superfamily, and is a negative regulator of muscle growth [1,2].”
BackgroundMyostatin in the Pathophysiology of Skeletal Muscle
Bonnieu, A., Carnac, G., & Vernus, B. (2007) · Current Genomics · doi:10.2174/138920207783591672 · Cited by 123
“After cleavage of the signal sequence and proteolytic processing, the mature C-terminal dimer remains associated with the propeptide via non-covalent forces creating a latent complex from which myostatin must be released to elicit its biological activity [3-6].”
BackgroundRegulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells
Huang, Z., Chen, D., Zhang, K., Yu, B., Chen, X., & Meng, J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.07.002 · Cited by 121
Campos, C., Valente, L. M. P., Borges, P., Bizuayehu, T. T., & Fernandes, J. M. O. (2009) · Journal of Experimental Biology · doi:10.1242/jeb.033126 · Cited by 103
“Growth factors such as Mstn have been identified as key peptides in the regulation of myogenesis in vertebrates by repressing skeletal muscle growth through inhibiting both muscle cell hypertrophy and hyperplasia (Lee and McPherron, 2001; Terova et al., 2006; Thomas et al., 2000; Xu et al., 2003).”
BackgroundJohnston, I. A., Manthri, S., Smart, A., Campbell, P., Nickell, D., & Alderson, R. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00577 · Cited by 103
“Based on the analysis of cell cycle control proteins, it has been suggested that MSTN signalling upregulates p21, inhibiting cyclin-E–Cdk2 activity, causing the hypophosphorylation of retinoblastoma protein and arrest at the G1 gap phase of the cell cycle (Thomas et al., 2000).”
BackgroundMarcell, T. J., Harman, S. M., Urban, R. J., Metz, D. D., Rodgers, B. D., & Blackman, M. R. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1159 · Cited by 103
“Myostatin functionally decreases protein synthesis by inhibiting cell proliferation and DNA synthesis by blocking satellite cell (myoblast) activity (25, 26).”
BackgroundStinckens, A., Luyten, T., Bijttebier, J., den Maagdenberg, K. V., Dieltiens, D., Janssens, S., SMET, S. D., Georges, M., & Buys, N. (2008) · Animal Genetics · doi:10.1111/j.1365-2052.2008.01774.x · Cited by 126
Understanding Muscle Architectural Adaptation: Macro- and Micro-Level Research
Blazevich, A. J., & Sharp, N. C. C. (2005) · Cells Tissues Organs · doi:10.1159/000089964 · Cited by 124
“Increased levels of either local cytokines or myostatin therefore prevents the differentiation of myoblasts in skeletal muscle, and causes early cell cycle arrest and reduced myogenesis [Thomas et al., 2000; Joulia et al., 2003].”
BackgroundKim, J.-S., Petrella, J. K., Cross, J. M., & Bamman, M. M. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01194.2006 · Cited by 100
“Studies have shown that C2C12 myoblasts in growth media are arrested in the G1 phase of the cell cycle by the addition of myostatin, which concomitantly leads to marked induction of p21 (24, 44).”
Skeletal muscle signature of a champion sprint runner
Trappe, S., Luden, N., Minchev, K., Raue, U., Jemiolo, B., & Trappe, T. A. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00037.2015 · Cited by 100
Marchitelli, C., Savarese, M. C., Crisà, A., Nardone, A., Marsan, P. A., & Valentini, A. (2003) · Mammalian Genome · doi:10.1007/s00335-002-2176-5 · Cited by 100
The Function of Myostatin in the Regulation of Fat Mass in Mammals
Deng, B., Zhang, F., Wen, J., Ye, S., Wang, L., Yang, Y., Gong, P., & Jiang, S. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0179-1 · Cited by 98
Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2
Lee, Y.-S., & Lee, S.-J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309907110 · Cited by 99
“The mechanisms by which MSTN loss leads to improved muscle healing are not fully understood, but studies have suggested that MSTN is capable of inhibiting myoblast proliferation by arresting cell cycles in the G1 phase (34) and blocking myoblast differentiation by inhibiting MyoD activity (35).”
BackgroundWeber, T. E., & Bosworth, B. G. (2005) · Aquaculture · doi:10.1016/j.aquaculture.2005.02.032 · Cited by 99
Kerr, T., Roalson, E. H., & Rodgers, B. D. (2005) · Evolution & Development · doi:10.1111/j.1525-142x.2005.05044.x · Cited by 107
Chopard, A., Hillock, S., & Jasmin, B. J. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00864.x · Cited by 117
“During skeletal muscle development, it has been shown that myostatin overexpression inhibits myoblast proliferation, differentiation, and apoptosis [129, 130].”
BackgroundMechanisms of cisplatin-induced muscle atrophy
Sakai, H., Sagara, A., Arakawa, K., Sugiyama, R., Hirosaki, A., Takase, K., Jo, A., Sato, K., Chiba, Y., Yamazaki, M., et al. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.05.001 · Cited by 106
“It has been documented that Mstn suppresses muscle cell growth via transcriptional upregulation of the cyclin-dependent kinase (Cdk) inhibitor p21 (Thomas et al., 2000).”
BackgroundMyostatin Up-Regulation Is Associated with the Skeletal Muscle Response to Hypoxic Stimuli
Hayot, M., Rodriguez, J., Vernus, B., Carnac, G., Jean, E., Allen, D., Goret, L., Obert, P., Candau, R., & Bonnieu, A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.09.008 · Cited by 98
McMahon, C. D., Popovic, L., Oldham, J. M., Jeanplong, F., Smith, H. K., Kambadur, R., Sharma, M., Maxwell, L., & Bass, J. J. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00275.2002 · Cited by 96
“However, these protein forms dimerize in vivo in a manner that is resistant to reducing conditions and heat; moreover, there are secondary posttranslational modifications such as glycosylation that give rise to precursor, LAP, and mature peptides migrating at 52, 40, and 26-30 kDa, respectively (6, 14, 25, 26).”
Self-citationRunx1 Transcription Factor Is Required for Myoblasts Proliferation during Muscle Regeneration
Umansky, K. B., Gruenbaum-Cohen, Y., Tsoory, M., Feldmesser, E., Goldenberg, D., Brenner, O., & Groner, Y. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1005457 · Cited by 91
“Expressed in muscleMstn serves as a negative regulator of muscle mass [46] and as attenuator of myoblast [47] and SC proliferation [48].”
BackgroundChelh, I., Meunier, B., Picard, B., Reecy, M. J., Chevalier, C., Hocquette, J.-F., & Cassar-Malek, I. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-196 · Cited by 91
“Examination of the molecular action of MSTN has revealed an inhibitory influence on proliferation through the control of cell cycle progression [10,11].”
Dieli-Conwright, C. M., Spektor, T. M., Rice, J. C., Sattler, F. R., & Schroeder, E. T. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00590.2009 · Cited by 91
“statin (2), may be upregulated (39) by binding to the ACTIIB”
BackgroundInfluentialMolecular mechanisms of intensive care unit-acquired weakness
Bloch, S., Polkey, M. I., Griffiths, M., & Kemp, P. (2012) · European Respiratory Journal · doi:10.1183/09031936.00090011 · Cited by 90
Frost, R. A., Nystrom, G. J., & Lang, C. H. (2003) · Endocrinology · doi:10.1210/en.2002-220808 · Cited by 89
Rabinovich, R. A., Drost, E., Manning, J. R., Dunbar, D. R., Díaz-Ramos, M., Lakhdar, R., Bastos, R., & MacNee, W. (2015) · Respiratory Research · doi:10.1186/s12931-014-0139-5 · Cited by 88
Role of lncRNAs in aging and age‐related diseases
He, J., Tu, C., & Liu, Y. (2018) · Aging Medicine · doi:10.1002/agm2.12030 · Cited by 91
“Stimulated by myostatin, MALAT1 regulates muscle cell proliferation and differentiation, thus influencing muscle aging.(204,205) SIRT1‐AS was recently reported to play a role in myogenesis, as its”
BackgroundRole of myostatin in metabolism
Gonzalez-Cadavid, N. F., & Bhasin, S. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000134365.99523.7f · Cited by 88
The effects of a mutation in the myostatin gene on meat and carcass quality
Wiener, P., Woolliams, J. A., Frank-Lawale, A. S., Ryan, M. T., Richardson, R. I., NUTE, G. R., Wood, J. D., Homer, D., & Williams, J. L. (2009) · Meat Science · doi:10.1016/j.meatsci.2009.04.010 · Cited by 102
Østbye, T.-K. K., Wetten, O. F., Tooming‐Klunderud, A., Jakobsen, K. S., Yafe, A., Etzioni, S., Moen, T., & Andersen, Ø. (2007) · Gene · doi:10.1016/j.gene.2007.08.008 · Cited by 94
Mighty is a novel promyogenic factor in skeletal myogenesis
Marshall, A. D., Salerno, M. S., Thomas, M., Davies, T. J., Berry, C., Dyer, K. A., Bracegirdle, J., Watson, T. J., Dziadek, M. A., Kambadur, R., et al. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.01.004 · Cited by 89
Self-citationRevisiting the paradigm of myostatin in vertebrates: Insights from fishes
Gabillard, J., Biga, P. R., Rescan, P., & Seiliez, I. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.08.012 · Cited by 94
“In mammals, MSTN inhibits both proliferation and differentiation of myoblasts (Thomas et al., 2000; Langley et al., 2002) and maintains satellite cells in a quiescent state (McCroskery et al., 2003).”
BackgroundEmbryonic and tissue-specific regulation of myostatin-1 and -2 gene expression in zebrafish
Helterline, D., Garikipati, D. K., Stenkamp, D. L., & Rodgers, B. D. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2006.12.023 · Cited by 88
Current pharmacotherapies for sarcopenia
Hardee, J. P., & Lynch, G. S. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1622093 · Cited by 84
“Myostatin may also potentially regulate skeletal muscle mass through inhibition of myoblast proliferation and myogenic differentiation [29,30].”
BackgroundThe Role of the Skeletal Muscle Secretome in Mediating Endurance and Resistance Training Adaptations
Leuchtmann, A. B., Adak, V., Dilbaz, S., & Handschin, C. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.709807 · Cited by 84
“Myostatin Myostatin is a highly conserved member of the TGF-β protein family and is mainly expressed in skeletal muscle (Thomas et al., 2000).”
Background
Metadata
- Authors
- Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R.
- Affiliations
- AgResearch (NZ)
- Corresponding author
- Kambadur, Ravi
- ORCID
- Langley, Brett
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 275
- Issue
- 51
- Pages
- 40235-40243
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2128303661
- Semantic Scholar
- 1d23c762e638a24e032fb334a031fafce76bc3ab
- Cited by
- 1,014
- References
- 34
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 21 · 2023: 33 · 2022: 35 · 2021: 39 · 2020: 33 · 2019: 37 · 2018: 33 · 2017: 40 · 2016: 46 · 2015: 38 · 2014: 52 · 2013: 58 · 2012: 55
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7240 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- myostatin, myoblast proliferation, muscle growth, myogenesis, G1 cell cycle arrest, p21, CDK2, retinoblastoma protein, C2C12 myoblasts, TGF-beta superfamily, muscle precursor cells
- MeSH terms
- Animals, Base Sequence, Cattle, Cell Cycle, Cell Division, Cells, Cultured, Hydrolysis, Phosphorylation, Retinoblastoma Protein, Transforming Growth Factor beta, DNA Primers, Muscle, Skeletal, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.